NOVAVAX INC Tax Withholding Paid on Stock Awards
NOVAVAX INC (NVAX) reported Tax Withholding Paid on Stock Awards of $39.09 million for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-01.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2021-03-01
- NOVAVAX INC payment, tax withholding, share-based payment arrangement for fiscal 2020 was $39.09M.
- NOVAVAX INC payment, tax withholding, share-based payment arrangement for fiscal 2019 was $0.00.
- NOVAVAX INC payment, tax withholding, share-based payment arrangement for fiscal 2018 was $0.00.
| Period end | Payment, Tax Withholding, Share-based Payment Arrangement 12 month |
|---|---|
| 2020-12-31 | $39.09M 10-K · filed 2021-03-01 |
| 2019-12-31 | $0.00 10-K · filed 2021-03-01 |
| 2018-12-31 | $0.00 10-K · filed 2021-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |